1. Home
  2. WBX vs GNFT Comparison

WBX vs GNFT Comparison

Compare WBX & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WBX
  • GNFT
  • Stock Information
  • Founded
  • WBX 2015
  • GNFT 1999
  • Country
  • WBX Spain
  • GNFT France
  • Employees
  • WBX N/A
  • GNFT N/A
  • Industry
  • WBX Industrial Specialties
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WBX Consumer Discretionary
  • GNFT Health Care
  • Exchange
  • WBX Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • WBX 102.7M
  • GNFT 214.5M
  • IPO Year
  • WBX N/A
  • GNFT 2019
  • Fundamental
  • Price
  • WBX $5.65
  • GNFT N/A
  • Analyst Decision
  • WBX Buy
  • GNFT Strong Buy
  • Analyst Count
  • WBX 3
  • GNFT 1
  • Target Price
  • WBX $0.72
  • GNFT $13.00
  • AVG Volume (30 Days)
  • WBX 496.2K
  • GNFT 4.2K
  • Earning Date
  • WBX 07-31-2025
  • GNFT 04-24-2025
  • Dividend Yield
  • WBX N/A
  • GNFT N/A
  • EPS Growth
  • WBX N/A
  • GNFT N/A
  • EPS
  • WBX N/A
  • GNFT 0.03
  • Revenue
  • WBX $171,352,140.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • WBX N/A
  • GNFT $15.98
  • Revenue Next Year
  • WBX $44.10
  • GNFT N/A
  • P/E Ratio
  • WBX N/A
  • GNFT $125.30
  • Revenue Growth
  • WBX 3.75
  • GNFT 105.01
  • 52 Week Low
  • WBX $0.23
  • GNFT $2.55
  • 52 Week High
  • WBX $5.99
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • WBX 34.74
  • GNFT 47.81
  • Support Level
  • WBX $5.80
  • GNFT $3.61
  • Resistance Level
  • WBX $6.36
  • GNFT $3.95
  • Average True Range (ATR)
  • WBX 0.64
  • GNFT 0.14
  • MACD
  • WBX -0.06
  • GNFT -0.01
  • Stochastic Oscillator
  • WBX 38.62
  • GNFT 57.01

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: